GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Short-Term Capital Lease Obligation

Edwards Lifesciences (LTS:0REN) Short-Term Capital Lease Obligation : CHF22 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Short-Term Capital Lease Obligation?

Edwards Lifesciences's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF22 Mil.

Edwards Lifesciences's quarterly Short-Term Capital Lease Obligation declined from Jun. 2023 (CHF22 Mil) to Sep. 2023 (CHF22 Mil) and declined from Sep. 2023 (CHF22 Mil) to Dec. 2023 (CHF22 Mil).

Edwards Lifesciences's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (CHF23 Mil) to Dec. 2022 (CHF24 Mil) but then declined from Dec. 2022 (CHF24 Mil) to Dec. 2023 (CHF22 Mil).


Edwards Lifesciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Edwards Lifesciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Short-Term Capital Lease Obligation Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.06 24.16 23.49 23.76 21.53

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.23 21.88 21.86 21.53 22.04

Edwards Lifesciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Edwards Lifesciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (LTS:0REN) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines